Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry W Goy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Urology|February 9, 2020
AUTHOR REPLYBarry W Goy
Brachytherapy|June 6, 2021
Ten-year treatment complication outcomes of radical prostatectomy vs external beam radiation vs brachytherapy for 1503 patients with intermediate risk prostate cancerBarry W Goy, Raoul Burchette
Prostate International|January 21, 2022
Twelve-year outcomes of prostate cancer after radical prostatectomy for T3 and/or positive margins managed with surveillance or salvage radiation therapy, based on risk groupsBarry W Goy, In-Lu Amy Liu
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 10, 2021
The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experienceBarry W Goy, Sajjad Syed, Aswini Padmanabhan, et al.
Urology|November 10, 2019
Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate CancerBarry W Goy, Raoul Burchette, Margaret S Soper, et al.
Brachytherapy|September 8, 2016
Treatment results of brachytherapy vs. external beam radiation therapy for intermediate-risk prostate cancer with 10-year followupBarry W Goy, Margaret S Soper, Tangel Chang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Urology|February 9, 2020
AUTHOR REPLYBarry W Goy
Brachytherapy|June 6, 2021
Ten-year treatment complication outcomes of radical prostatectomy vs external beam radiation vs brachytherapy for 1503 patients with intermediate risk prostate cancerBarry W Goy, Raoul Burchette
Prostate International|January 21, 2022
Twelve-year outcomes of prostate cancer after radical prostatectomy for T3 and/or positive margins managed with surveillance or salvage radiation therapy, based on risk groupsBarry W Goy, In-Lu Amy Liu
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 10, 2021
The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experienceBarry W Goy, Sajjad Syed, Aswini Padmanabhan, et al.
Urology|November 10, 2019
Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate CancerBarry W Goy, Raoul Burchette, Margaret S Soper, et al.
Brachytherapy|September 8, 2016
Treatment results of brachytherapy vs. external beam radiation therapy for intermediate-risk prostate cancer with 10-year followupBarry W Goy, Margaret S Soper, Tangel Chang, et al.
Pageof 1